Quantification of doripenem in human plasma and peritoneal fluid by high-performance liquid chromatography with ultraviolet detection

被引:39
作者
Ikeda, Kayo [1 ]
Ikawa, Kazuro [1 ]
Morikawa, Norifumi [1 ]
Kameda, Keiko [1 ]
Urakawa, Nami [1 ]
Ohge, Hiroki [2 ]
Sueda, Taijiro [2 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Clin Pharmacotherapy, Minami Ku, Hiroshima 7348551, Japan
[2] Hiroshima Univ, Grad Sch Biomed Sci, Dept Surg, Minami Ku, Hiroshima 7348551, Japan
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2008年 / 867卷 / 01期
关键词
doripenem; ultrafiltration; HPLC; plasma; peritoneal fluid; pharmacokinetic studies;
D O I
10.1016/j.jchromb.2008.03.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple and rapid HPLC method that includes ultrafiltration to remove plasma and peritoneal fluid protein was developed to determine doripenem concentrations in human plasma and peritoneal fluid. Doripenem was stabilized by immediate mixing of the plasma or peritoneal fluid with 1 M 3-morpholinopropanesulfonic acid buffer (pH 7.0) (1: 1). Doripenem and an internal standard were detected by measuring their ultraviolet absorbance at 300 nm. The calibration curves for doripenem in human plasma and peritoneal fluid were linear from 0.05 to 100 mu g/mL. For plasma, both the intra- and the inter-day precision were less than 3.41% (CV), and the accuracy was between 97.4 and 101.7% above 0.05 mu g/mL. For peritoneal fluid, the intra- and the interday precision were less than 2.98% (CV), and the accuracy was between 94.4 and 103.9% above 0.05 mu g/mL. The limit of detection was 0.02 mu g/mL in both plasma and peritoneal fluid. The assay has been applied to the therapeutic drug monitoring of doripenem in both plasma and peritoneal fluid. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 12 条
[1]   Doripenem [J].
Anderson, David Leif .
DRUGS OF TODAY, 2006, 42 (06) :399-404
[2]   Use of pharmacokinetic-pharmaco dynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem [J].
Bhavnani, SM ;
Hammel, JP ;
Cirincione, BB ;
Wikler, MA ;
Ambrose, PG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (09) :3944-3947
[3]   Determination of imipenem in plasma by high-performance liquid chromatography for pharmacokinetic studies in patients [J].
GarciaCapdevila, L ;
LopezCalull, C ;
Arroyo, C ;
Moral, MA ;
Mangues, MA ;
Bonal, J .
JOURNAL OF CHROMATOGRAPHY B, 1997, 692 (01) :127-132
[4]  
Ikawa K, 2006, JPN J PHARM HLTH CAR, V32, P622
[5]  
Ikawa K, 2004, JPN J PHARM HLTH CAR, V30, P438
[6]   High-performance liquid chromatography with ultraviolet detection for real-time therapeutic drug monitoring of meropenem in plasma [J].
Ikeda, Kayo ;
Ikawa, Kazuro ;
Morikawa, Norifumi ;
Miki, Mizuka ;
Nishimura, Shin-Ichiro ;
Kobayashi, Masao .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 856 (1-2) :371-375
[7]   A simple and rapid determination of biapenem in plasma by high-performance liquid chromatography [J].
Ikeda, Kayo ;
Ikawa, Kazuro ;
Ikeda, Aki ;
Nishikawa, Yoshimi ;
Morikawa, Norifumi .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2006, 844 (01) :148-152
[8]   Doripenem (S-4661), a novel carbapenem:: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations [J].
Jones, RN ;
Huynh, HK ;
Biedenbach, DJ ;
Fritsche, TR ;
Sader, HS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (01) :144-154
[9]   Comparative stability of carbapenem and penem antibiotics to human recombinant dehydropeptidase-I [J].
Mori, M ;
Hikida, M ;
Nishihara, T ;
Nasu, T ;
Misuhashi, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (05) :1034-1036
[10]   Development of an HPLC method for the determination of doripenem in human and mouse serum [J].
Sutherland, Christina ;
Nicolau, David P. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 853 (1-2) :123-126